D ENVER -- Patients who discontinued treatment for advanced kidney cancer because of immune-related adverse events (irAEs) ...

Lymphovascular invasion in RCC is associated with upstaging and worse survival outcomes. Patients with lymphovascular invasion are at increased risk for renal cell carcinoma (RCC) upstaging and worse ...

Limited data exist on outcomes in mRCC patients with major venous involvement (MVI). Assessment of impact of a given variable on prognosis in cancer patients is challenging given competing causes of ...

Ongoing research in renal cell carcinoma (RCC) suggests that hypoxia-inducible factor 2-alpha (HIF-2α) inhibitors are poised ...

DPI-4452 targets CAIX in tumors, offering noninvasive diagnostic potential for ccRCC with favorable tolerability. The agent is part of a theranostic pair wi ...

DENVER -- Patients with advanced kidney cancer treated with immune checkpoint inhibitors (ICIs) lived longer if they consumed ...

Higher body mass index (BMI) after diagnosis is linked to better survival outcomes in patients with localized renal cell ...

Phase I Study Combining Treatment With Temsirolimus and Sunitinib Malate in Patients With Advanced Renal Cell Carcinoma This phase I study evaluated temsirolimus in combination with sunitinib in ...

The management of renal cell carcinoma (RCC) has transformed over the past 20 years, and recent advances in diagnostic and therapeutic modalities have the potential to further improve patient outcomes ...